Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2026-01-07 @ 6:49 PM
Study NCT ID:
NCT02799095
Status:
COMPLETED
Last Update Posted:
2025-05-21
First Post:
2016-06-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors
Sponsor:
Mural Oncology, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALK4230-A101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None